Genome-scale functional mapping of the mammalian whole brain with in vivo Perturb-seq
Preprint
Abstract
Functional genomics studies have provided critical insights into cell type-specific gene regulatory programs, but to date most have been conducted in wild-type tissues or cell cultures. Here, we present a gene expression functional atlas across the mouse brain. We use an enhanced in vivo Perturb-seq platform to analyze transcriptome-wide responses to loss of 1,947 disease-associated genes, profiling over 7.7 million cells spanning major brain regions and neuronal populations. We find striking cell-type-specific essentiality and transcriptional programs and show that closely related disease genes such as two NMDA receptor subunits can drive opposing transcriptional programs. Together, this work reveals insights into the genetics and mechanisms of neurodevelopmental, psychiatric, and neurodegenerative diseases in vivo, paving the way for the design of future genetic medicine.Keywords
Funding Information
- National Institute of Health (R01MH125516, R01HG012819, R01MH137042)
- Medical Research Council Centre of Research Excellence in Therapeutic Genomics (MR/Z504725/1)
- Health Data Research UK QQ2 Molecules to Health Records Driver Programme
- Simons Foundation (SFARI #736613)
- California Institute for Regenerative Medicine (DISC4-16295)
- One Mind Foundation
- Conrad Prebys Foundation
- James Fickel and Jed McCaleb
This publication has 84 references indexed in Scilit:
- Probing neuropsychiatric disorders through in vivo CRISPR screeningCurrent Opinion in Genetics & Development, 2025
- Massively parallel in vivo Perturb-seq reveals cell-type-specific transcriptional networks in cortical developmentCell, 2024
- Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seqCell, 2022
- Scaling national and international improvement in virtual gene panel curation via a collaborative approach to discordance resolutionThe American Journal of Human Genetics, 2021
- MEF2C Hypofunction in Neuronal and Neuroimmune Populations Produces MEF2C Haploinsufficiency Syndrome–like Behaviors in MiceBiological Psychiatry, 2020
- YY1 Is a Structural Regulator of Enhancer-Promoter LoopsCell, 2017
- Defective minor spliceosome mRNA processing results in isolated familial growth hormone deficiencyEMBO Molecular Medicine, 2014
- Targeting MLL1 H3K4 Methyltransferase Activity in Mixed-Lineage LeukemiaMolecular Cell, 2014
- A Missense Mutation in PRPF6 Causes Impairment of pre-mRNA Splicing and Autosomal-Dominant Retinitis PigmentosaThe American Journal of Human Genetics, 2011
- Developmental and regional expression in the rat brain and functional properties of four NMDA receptorsNeuron, 1994